Industry News (Funding)

Boston Biomedica Awarded Three NIH SBIR Grants

Published in Vaccine Weekly, September 27th, 1999

Boston Biomedica, Inc., announced that BBI Biotech Research Laboratories (a wholly-owned subsidiary of Boston Biomedica) has been awarded three U.S. National Institutes of Health Small Business Innovation Research (SBIR) grants totaling approximately $850,000 relating to the company's research and development efforts in nucleic acid testing for infectious diseases.

The first grant is a six-month Phase I award of approximately $100,000 for preliminary development of a sensitive and specific polymerase chain reaction (PCR) assay for Babesia DNA to be used in both the early diagnosis of babesiosis and in the monitoring of therapy.

Babesiosis is...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (1999-09-27)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry